Lv4
510 积分 2024-01-11 加入
[Chinese experts consensus on the diagnosis and management of checkpoint inhibitor pneumonitis(2025)]
27天前
已完结
Efficacy and Safety of KRAS G12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study
28天前
已完结
Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial
29天前
已完结
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
1个月前
已完结
[Guideline for HER2 testing in breast cancer (2024 version)]
2个月前
已完结
Bystander effect of antibody–drug conjugates: fact or fiction?
2个月前
已完结
Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non–Small Cell Lung Cancer
2个月前
已完结
[Annual therapeutic advances in advanced non-small cell lung cancer in 2024]
2个月前
已完结
[Expert consensus on immunotherapy for small cell lung cancer (2025 edition)]
2个月前
已完结
Design and Generation of DVD-Ig™ Molecules for Dual-Specific Targeting
2个月前
已完结
皖公网安备34019202002308
